BMO Capital analyst David Gagliano maintains Steel Dynamics (NASDAQ:STLD) with a Market Perform and raises the price target from $89 to $100.
Evercore ISI Group Upgrades BioCryst Pharmaceuticals to Outperform, Announces $16 Price Target
Evercore ISI Group analyst Liisa Bayko upgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from In-Line to Outperform and announces $16 price target.